QWM
GPCR icon

Quadcap Wealth Management’s Structure Therapeutics GPCR Stock Holding History

Quadcap Wealth Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Sell
4,729
-2,754
-37% -$188K 0.03% 356
2025
Q4 		$355K Buy
+7,483
New +$306K 0.04% 301
2025
Q1 		– Sell
-7,851
Closed -$213K – 393
2024
Q4 		$213K Sell
7,851
-949
-11% -$33.7K 0.03% 352
2024
Q3 		$386K Sell
8,800
-135
-2% -$5.22K 0.06% 277
2024
Q2 		$351K Buy
8,935
+949
+12% +$39K 0.06% 285
2024
Q1 		$342K Buy
+7,986
New +$337K 0.08% 252

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quadcap Wealth Management's GPCR Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Structure Therapeutics (GPCR) stake by 37% in Q1 2026, selling an estimated $188K and leaving 4,729 shares worth $228K. The position accounts for 0.03% of the portfolio, ranked #356.

Quadcap Wealth Management first reported a position in GPCR in Q1 2024 and has held it in 6 quarters since. The position peaked at $386K in Q3 2024. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Quadcap Wealth Management held 4,729 shares of Structure Therapeutics worth $228K as of Q1 2026.
  • Quadcap Wealth Management sold 2,754 Structure Therapeutics shares in Q1 2026, an estimated $188K.
  • Structure Therapeutics made up 0.03% of Quadcap Wealth Management's portfolio in Q1 2026, its #356 holding.
  • Quadcap Wealth Management first reported a position in Structure Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Quadcap Wealth Management's Structure Therapeutics position peaked at $386K in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.